The synthesis and characterization of BMS-204352 (MaxiPost™) and related 3-fluorooxindoles as openers of maxi-K potassium channels

被引:140
作者
Hewawasam, P
Gribkoff, VK
Pendri, Y
Dworetzky, SI
Meanwell, NA
Martinez, E
Boissard, CG
Post-Munson, DJ
Trojnacki, JT
Yeleswaram, K
Pajor, LM
Knipe, J
Gao, Q
Perrone, R
Starrett, JE
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Chem, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Neurosci, Wallingford, CT 06492 USA
[3] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Proc Res & Dev, Wallingford, CT 06492 USA
[4] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Metab & Pharmacokinet, Wallingford, CT 06492 USA
[5] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Analyt Res & Dev, Wallingford, CT 06492 USA
[6] Bristol Myers Squibb Pharmaceut Res Inst, Dept Pharmaceut, New Brunswick, NJ 08903 USA
关键词
D O I
10.1016/S0960-894X(02)00101-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
3-Aryl-3-fluorooxindoles can be efficiently synthesized in two steps by the addition of an aryl Grignard to an isatin, followed by treatment with DAST. Oxindole 1 (BMS-204352; MaxiPost(TM)) can be isolated using chiral HPLC or prepared by employing chiral resolution. Cloned maxi-K channels are opened by 1, which demonstrates a brain/plasma ratio > 9 in rats. (C) 2002 Elsevier Science Ltd, All rights reserved.
引用
收藏
页码:1023 / 1026
页数:4
相关论文
共 13 条
  • [1] Gribkoff V.K., 1997, 3-substituted oxindole derivatives as potassium channel modulators,, Patent No. [US5602169, 5602169, US5602169A]
  • [2] Maxi-K potassium channels: Form, function, and modulation of a class of endogenous regulators of intracellular calcium
    Gribkoff, VK
    Starrett, JE
    Dworetzky, SI
    [J]. NEUROSCIENTIST, 2001, 7 (02) : 166 - 177
  • [3] Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels
    Gribkoff, VK
    Starrett, JE
    Dworetzky, SI
    Hewawasam, P
    Boissard, CG
    Cook, DA
    Frantz, SW
    Heman, K
    Hibbard, JR
    Huston, K
    Johnson, G
    Krishnan, BS
    Kinney, GG
    Lombardo, LA
    Meanwell, NA
    Molinoff, PB
    Myers, RA
    Moon, SL
    Ortiz, A
    Pajor, L
    Pieschl, RL
    Post-Munson, DJ
    Signor, LJ
    Srinivas, N
    Taber, MT
    Thalody, G
    Trojnacki, JT
    Wiener, H
    Yeleswaram, K
    Yeola, SW
    [J]. NATURE MEDICINE, 2001, 7 (04) : 471 - 477
  • [4] Gribkoff VK, 1996, MOL PHARMACOL, V50, P206
  • [5] Discovery of a novel class of BK channel openers: Enantiospecific synthesis and BK channel opening activity of 3-(5-chloro-2-hydroxyphenyl)-1,3-dihydro-3-hydroxy-6-(trifluoromethyl)-2H-indol-2-one
    Hewawasam, P
    Meanwell, NA
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (10) : 1255 - 1260
  • [6] HEWAWASAM P, IN PRESS J MED CHEM
  • [7] Hille B., 1992, IONIC CHANNELS EXCIT
  • [8] HINRICHSEN RD, 1993, CALCIUM DEPENDENT PO
  • [9] VARIETIES OF CALCIUM-ACTIVATED POTASSIUM CHANNELS
    LATORRE, R
    OBERHAUSER, A
    LABARCA, P
    ALVAREZ, O
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1989, 51 : 385 - 399
  • [10] PENDRI YR, 1998, Patent No. 5892106